Proteomic and Metabolomic Features in Patients with HCC Responding to Lenvatinib and Anti-Pd1 Therapy
Cell Reports（2024）
Key words
hepatocellular carcinoma,PD1,lenvatinib,proteomics,metabolomics,complement,lysophosphatidylcholine,immunotherapy,combination therapy,machine learning
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined